Pulse Biosciences Inc (PLSE)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $3.71B
Last updated: Nov 17, 2026 at 4:33 PM ET
Pulse Biosciences Inc (PLSE) Stock Chart
Pulse Biosciences (PLSE) has a latest price of $44.84 on Nov 17, 2026, 23.9% below its 52-week high of $58.94. Its price rose 211.4% over the past 12 months. The month-end price rose 753.6% over the 10 years through Oct 2026, a compound annual rate of 23.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $52.24 in Oct 2026 and its lowest $1.27 in Aug 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PLSE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PLSE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 4.6%, and over 6 months it rose 79.7%. The month-end price rose 1,055.8% over the 3 years through Oct 2026, a compound annual rate of 126.1%.
| Period | Change |
|---|---|
| 1 month | -5.7% |
| 3 months | -4.6% |
| 6 months | +79.7% |
| 12 months | +211.4% |
| 12 months, with dividends | +211.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +1,055.8% | +126.1% |
| 5 years | +147.7% | +19.9% |
| 10 years | +753.6% | +23.9% |
Price by Year
Its best calendar year was 2023, when the price rose 341.9%, and its weakest was 2022, when it fell 81.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $52.24 | +280.5% |
| 2025 | $13.73 | -21.1% |
| 2024 | $17.41 | +42.2% |
| 2023 | $12.24 | +341.9% |
| 2022 | $2.77 | -81.3% |
| 2021 | $14.81 | -37.9% |
| 2020 | $23.86 | +77.9% |
| 2019 | $13.41 | +17.0% |
| 2018 | $11.46 | -51.4% |
| 2017 | $23.60 | +263.1% |
Trading Range
The price is 13.2% below its 50-day average of $51.64 and 33.2% above its 200-day average of $33.66.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $44.84 | |
| 52-week high | $58.94 | -23.9% |
| 52-week low | $12.56 | +257.0% |
| 50-day average | $51.64 | -13.2% |
| 200-day average | $33.66 | +33.2% |
Price Risk
Over 3 years, its largest fall from a peak was 48.5%.
| Measure | Value |
|---|---|
| 1-year beta | 2.09 |
| Largest fall, 1 year | -29.5% |
| Largest fall, 3 years | -48.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PLSE
What is PLSE's 1-year price change?
Pulse Biosciences's price rose 211.4% over the past 12 months. With dividends included, the 12-month total return was 211.4%.
What is PLSE's 5-year price change?
Pulse Biosciences's month-end price rose 147.7% over the 5 years through Oct 2026, a compound annual rate of 19.9%. These figures leave out dividends.
What is PLSE's 52-week high and low?
Pulse Biosciences's 52-week high is $58.94 and its 52-week low is $12.56. Its latest price of $44.84 on Nov 17, 2026 is 23.9% below the high.
What is PLSE's beta?
Pulse Biosciences's 1-year beta against the S&P 500 is 2.09, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 29.5%.
Is the PLSE chart free?
Yes. Advanced Charting for PLSE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PLSE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors